Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China · Delayed Price · Currency is CNY 170.00
-0.44 (-0.26%)
At close: Feb 6, 2026
SHA:600436 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 2,420 | 2,977 | 2,797 | 2,472 | 2,432 | 1,672 |
Depreciation & Amortization | 94.6 | 94.6 | 102.38 | 80.36 | 133.49 | 90.21 |
Other Amortization | 9.91 | 9.91 | 26.31 | 15.34 | 15.96 | 12.46 |
Loss (Gain) From Sale of Assets | -4.66 | -4.66 | -1.5 | -11.48 | -28.91 | -40.95 |
Asset Writedown & Restructuring Costs | 0.79 | 0.79 | 0.54 | 1.8 | 2.34 | 0.66 |
Loss (Gain) From Sale of Investments | -136.79 | -136.79 | -134.51 | -75.19 | -23.35 | -61.94 |
Provision & Write-off of Bad Debts | 2.94 | 2.94 | 12.27 | -6.78 | 7.1 | 2.95 |
Other Operating Activities | -194.61 | 60.21 | 89.36 | 123.88 | 100.42 | 62.25 |
Change in Accounts Receivable | 272.9 | 272.9 | -181.92 | 4,258 | -2,089 | -222.1 |
Change in Inventory | -1,600 | -1,600 | -758.78 | -199.39 | -261.56 | -74.87 |
Change in Accounts Payable | -363.45 | -363.45 | 306.43 | 205.02 | 232.58 | 39.54 |
Operating Cash Flow | 501.55 | 1,314 | 2,207 | 6,873 | 462.27 | 1,467 |
Operating Cash Flow Growth | -55.46% | -40.47% | -67.89% | 1386.79% | -68.49% | - |
Capital Expenditures | -1,206 | -1,068 | -141.87 | -175.37 | -92.17 | -419.01 |
Sale of Property, Plant & Equipment | 6.62 | 4.13 | 1.25 | 13.74 | 5.31 | 86.19 |
Cash Acquisitions | - | - | - | - | - | -1.91 |
Investment in Securities | 2,237 | 2,354 | -2,658 | -6,170 | 143.32 | 15.04 |
Other Investing Activities | -544.15 | 34.52 | 24.12 | 27.03 | 21.82 | 37.66 |
Investing Cash Flow | 493.17 | 1,324 | -2,774 | -6,305 | 78.29 | -282.03 |
Short-Term Debt Issued | - | - | - | - | 1,410 | 1,058 |
Long-Term Debt Issued | - | 1,161 | 1,198 | 1,593 | - | - |
Total Debt Issued | 997.86 | 1,161 | 1,198 | 1,593 | 1,410 | 1,058 |
Short-Term Debt Repaid | - | - | - | - | -1,356 | -1,062 |
Long-Term Debt Repaid | - | -1,272 | -1,180 | -1,429 | -31.79 | - |
Total Debt Repaid | -1,175 | -1,272 | -1,180 | -1,429 | -1,387 | -1,062 |
Net Debt Issued (Repaid) | -177.25 | -111.2 | 17.85 | 164.12 | 23.09 | -4.46 |
Common Dividends Paid | -2,664 | -2,127 | -784.64 | -760.63 | -569.21 | -522.34 |
Other Financing Activities | -8.37 | -2.08 | -2.51 | 20.69 | 5.9 | -9.72 |
Financing Cash Flow | -2,850 | -2,241 | -769.3 | -575.82 | -540.23 | -536.52 |
Foreign Exchange Rate Adjustments | 2.04 | 8.16 | 2.43 | 11.44 | -4.62 | -6.26 |
Net Cash Flow | -1,853 | 405.7 | -1,334 | 3.84 | -4.29 | 642.26 |
Free Cash Flow | -704.71 | 245.41 | 2,065 | 6,698 | 370.11 | 1,048 |
Free Cash Flow Growth | - | -88.11% | -69.17% | 1709.66% | -64.69% | - |
Free Cash Flow Margin | -7.21% | 2.27% | 20.53% | 77.04% | 4.61% | 16.10% |
Free Cash Flow Per Share | -1.17 | 0.41 | 3.42 | 11.11 | 0.61 | 1.74 |
Cash Income Tax Paid | 930.96 | 1,167 | 1,155 | 989.67 | 969.09 | 821.62 |
Levered Free Cash Flow | 2,829 | -665.36 | 1,411 | 1,370 | 1,610 | 779.44 |
Unlevered Free Cash Flow | 2,849 | -641.85 | 1,434 | 1,394 | 1,631 | 796.56 |
Change in Working Capital | -1,690 | -1,690 | -685.58 | 4,273 | -2,177 | -270.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.